1. Home
  2. NRP vs MNKD Comparison

NRP vs MNKD Comparison

Compare NRP & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRP
  • MNKD
  • Stock Information
  • Founded
  • NRP 2002
  • MNKD 1991
  • Country
  • NRP United States
  • MNKD United States
  • Employees
  • NRP N/A
  • MNKD N/A
  • Industry
  • NRP Coal Mining
  • MNKD Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRP Energy
  • MNKD Health Care
  • Exchange
  • NRP Nasdaq
  • MNKD Nasdaq
  • Market Cap
  • NRP 1.3B
  • MNKD 1.2B
  • IPO Year
  • NRP N/A
  • MNKD 2004
  • Fundamental
  • Price
  • NRP $101.51
  • MNKD $5.49
  • Analyst Decision
  • NRP
  • MNKD Strong Buy
  • Analyst Count
  • NRP 0
  • MNKD 5
  • Target Price
  • NRP N/A
  • MNKD $10.80
  • AVG Volume (30 Days)
  • NRP 11.1K
  • MNKD 5.5M
  • Earning Date
  • NRP 11-04-2025
  • MNKD 11-06-2025
  • Dividend Yield
  • NRP 2.95%
  • MNKD N/A
  • EPS Growth
  • NRP N/A
  • MNKD 149.32
  • EPS
  • NRP 10.64
  • MNKD 0.11
  • Revenue
  • NRP $219,503,000.00
  • MNKD $301,736,000.00
  • Revenue This Year
  • NRP N/A
  • MNKD $14.52
  • Revenue Next Year
  • NRP N/A
  • MNKD $12.81
  • P/E Ratio
  • NRP $9.67
  • MNKD $50.09
  • Revenue Growth
  • NRP N/A
  • MNKD 21.48
  • 52 Week Low
  • NRP $81.74
  • MNKD $3.38
  • 52 Week High
  • NRP $113.04
  • MNKD $7.63
  • Technical
  • Relative Strength Index (RSI)
  • NRP 45.21
  • MNKD 67.74
  • Support Level
  • NRP $99.14
  • MNKD $5.36
  • Resistance Level
  • NRP $102.99
  • MNKD $5.68
  • Average True Range (ATR)
  • NRP 1.99
  • MNKD 0.30
  • MACD
  • NRP -0.29
  • MNKD 0.06
  • Stochastic Oscillator
  • NRP 34.80
  • MNKD 70.08

About NRP Natural Resource Partners LP Limited Partnership

Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. Geographically, the business activity of the group functions through the United States.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: